Table 2.
Different treatments on mice in the bacteriophage STP4-a safety assessment experiment.
| Groups | Number of mice | Treatment |
|---|---|---|
| F1 | 5 | Oral administration with SM buffer |
| F2 | 5 | Oral administration with inactivated bacteriophage STP4-a1 |
| F3 | 5 | Oral administration with bacteriophage STP4-a2 |
| M1 | 5 | Oral administration with SM buffer |
| M2 | 5 | Oral administration with inactivated bacteriophage STP4-a1 |
| M3 | 5 | Oral administration with bacteriophage STP4-a2 |
1
Five mice were orally administrated with phage STP4-a at the titer of 1.5 × 1010 pfu/mL/mouse.
2
Five mice were orally administrated with phage STP4-a autoclave-inactivated at the titer of 1.5 × 1010 pfu/mL/mouse.